hotspot -WSS

hotspot

author：explore 2025-10-01 16:38:18 - browse：113

Electrocardiogram in the shape of the United States map — Adobe

The market for artificial intelligence in health care is about as transparent as a brick wall. New tools achieve impressive results in published studies. But it is often difficult to compare them head to head with similar products, or tell whether they will work on different kinds of patients.

A new company is promising to change that — if it can convince AI developers to expose their products to more rigorous testing.

Called Dandelion Health, the New York-based firm is launching a first-of-its-kind public service to evaluate AI products on independent data designed to root out weaknesses and reveal bias. The company said Wednesday its initial pilot program, to begin next month, will focus on testing algorithms that use electrocardiograms to predict heart conditions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： STAT Readout: Friday, Oct. 20 biotech updates

hotspot

WSS

Why medical students are struggling with mental health

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Surge of respiratory disease in China has likely explanation

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Gain of function research would be limited under House proposal

leisure time

hotspot

focus

As demand for Covid shots wanes, Moderna seeks its next success

Roche drug slashes death risk in early

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT Readout Newsletter: Biotech news today

After affirmative action ruling, medical educators look to 'holistic review'

Roivant's CEO is a star, but biotech's black hole persists

DIEP, the 'gold standard' of breast reconstruction, is under threat

Is there really a nursing shortage in the U.S.?

Sports medicine is finally prioritizing gender equality

STAT Summit: Meghan O’Rourke on making chronic illness visible

Wikipedia

Health tech investors get more selective as pandemic boom fades

FDA clears Verve to begin U.S. study of gene

Weight loss drug costs may need more research, senator suggests

STAT Summit: Meghan O’Rourke on making chronic illness visible

STAT Readout: Friday, Oct. 20 biotech updates

STAT Readout: Friday, Oct. 20 biotech updates

hotspot

hotspot

entertainment

hotspot